Published in Adv Exp Med Biol on January 01, 1996
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35
Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J Exp Med (1993) 1.71
Major histocompatibility complex independent clonal T cell anergy by direct interaction of Staphylococcus aureus enterotoxin B with the T cell antigen receptor. J Exp Med (1992) 1.37
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy (2010) 1.24
The use of nitrocellulose immunoblots for the analysis of antigen recognition by T lymphocytes. J Immunol Methods (1988) 1.17
Functional evidence for a monoclonal antibody that binds to the human IL-4 receptor. Immunology (1988) 1.12
CD28 mRNA rapidly decays when activated T cells are functionally anergized with specific peptide. Int Immunol (1993) 1.02
In vivo clonal dominance and limited T-cell receptor usage in human CD4+ T-cell recognition of house dust mite allergens. Proc Natl Acad Sci U S A (1993) 1.02
Shellfish allergy. Clin Exp Allergy (2010) 1.01
Localization of the immunologic activity in the superantigen Staphylococcal enterotoxin B using truncated recombinant fusion proteins. J Immunol (1992) 0.97
Peptide-induced nonresponsiveness of HLA-DP restricted human T cells reactive with Dermatophagoides spp. (house dust mite). J Allergy Clin Immunol (1992) 0.96
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol (2012) 0.96
Follistatin is a candidate endogenous negative regulator of activin A in experimental allergic asthma. Clin Exp Allergy (2006) 0.93
IgE cross-reactivity between the major peanut allergen Ara h 2 and tree nut allergens. Mol Immunol (2006) 0.93
Antigen-induced neutrophil chemotactic factor from cloned human T lymphocytes. Immunology (1988) 0.93
Uncoupling of cytokine mRNA expression and protein secretion during the induction phase of T cell anergy. J Immunol (1992) 0.93
Role of intravenous immunoglobulin in severe steroid-dependent asthma. Intern Med J (2003) 0.92
Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient. Allergy (2009) 0.92
Immunological analysis of allergenic cross-reactivity between peanut and tree nuts. Clin Exp Allergy (2003) 0.92
VH gene usage in immunoglobulin E responses of seasonal rhinitis patients allergic to grass pollen is oligoclonal and antigen driven. Clin Exp Allergy (2004) 0.91
Clonal analysis of the atopic immune response to the group 2 allergen of Dermatophagoides spp.: identification of HLA-DR and -DQ restricted T cell epitopes. Int Immunol (1993) 0.91
Overlapping T-cell epitopes in the group I allergen of Dermatophagoides species restricted by HLA-DP and HLA-DR class II molecules. J Allergy Clin Immunol (1994) 0.91
Identification of two binding sites in staphylococcal enterotoxin B that confer specificity for TCR V beta gene products. Int Immunol (1994) 0.89
Synergy between dexamethasone and interleukin-5 for the induction of major histocompatibility complex class II expression by human peripheral blood eosinophils. Blood (1994) 0.88
Contribution of T-cell receptor-contacting and peptide-binding residues of the class II molecule HLA-DR4 Dw10 to serologic and antigen-specific T-cell recognition. Hum Immunol (1991) 0.87
Prevalence of severe ant-venom allergy in southeastern Australia. J Allergy Clin Immunol (1998) 0.86
An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential. Clin Exp Allergy (2012) 0.86
Oligoclonal V gene usage by T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients. Am J Respir Cell Mol Biol (1996) 0.86
Polyclonal and clonal analysis of human CD4+ T-lymphocyte responses to nut extracts. Immunology (1995) 0.86
Successful desensitization of two patients who previously developed Stevens-Johnson syndrome while receiving trimethoprim-sulfamethoxazole. Clin Infect Dis (1997) 0.85
Differential induction of the NF-AT complex during restimulation and the induction of T-cell anergy. Hum Immunol (1995) 0.84
Prevalence of IgE-mediated allergy to latex in hospital nursing staff. Aust N Z J Med (1997) 0.84
Allergen immunotherapy: current and new therapeutic strategies. Expert Opin Investig Drugs (2000) 0.84
The effects of changes at peptide residues contacting MHC class II T-cell receptor on antigen recognition and human Th0 cell effector function. Immunology (1995) 0.84
Altered T cell ligands derived from a major house dust mite allergen enhance IFN-gamma but not IL-4 production by human CD4+ T cells. J Immunol (1996) 0.84
Functional immunoglobulin E cross-reactivity between Pas n 1 of Bahia grass pollen and other group 1 grass pollen allergens. Clin Exp Allergy (2011) 0.83
Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers. Clin Exp Allergy (2004) 0.83
Ara h 1 CD4+ T cell epitope-based peptides: candidates for a peanut allergy therapeutic. Clin Exp Allergy (2013) 0.82
Latex allergy: a model for therapy. Clin Exp Allergy (2008) 0.81
Characterization of the T-cell epitopes of a major peanut allergen, Ara h 2. Allergy (2005) 0.81
Acute myopathy in severe acute asthma treated with intravenously administered corticosteroids. Am Rev Respir Dis (1988) 0.81
What can we learn from studies of lymphocytes present in allergic-reaction sites? J Allergy Clin Immunol (1992) 0.81
Reversal of the inhibitory effects of HIV-gp120 on CD4+ T cells by stimulation through the CD28 pathway. Clin Exp Immunol (1996) 0.81
HLA-DR4Dw4-restricted T cell recognition of self antigen(s) in the rheumatoid synovial compartment. Int Immunol (1991) 0.81
Analysis of the basis of resistance and susceptibility of CD4+ T cells to human immunodeficiency virus (HIV)-gp120 induced anergy. Immunology (1992) 0.81
Leukotriene release enhancing factor. Purification, specific allergen induction, and further biologic properties. J Immunol (1989) 0.81
HLA class II restriction specificity of Dermatophagoides spp. reactive T lymphocyte clones that support IgE synthesis. Clin Exp Allergy (1989) 0.80
Macadamia nut anaphylaxis: demonstration of specific IgE reactivity and partial cross-reactivity with hazelnut. J Allergy Clin Immunol (1999) 0.80
Adverse events associated with rush hymenoptera venom immunotherapy. Med J Aust (2001) 0.79
The evolution of oral immunotherapy for the treatment of peanut allergy. Clin Exp Allergy (2011) 0.79
A novel grass pollen allergen mimotope identified by phage display peptide library inhibits allergen-human IgE antibody interaction. FEBS Lett (2001) 0.79
The domain structure and functional relationships in the bacterial superantigen, SEB. Biol Chem Hoppe Seyler (1995) 0.78
Increased allergen concentration enhances IFN-gamma production by allergic donor T cells expressing a peripheral tissue trafficking phenotype. Allergy (2004) 0.78
Molecular cloning, expression and immunological characterisation of Lol p 5C, a novel allergen isoform of rye grass pollen demonstrating high IgE reactivity. FEBS Lett (1999) 0.78
The hevein domain of the major latex-glove allergen Hev b 6.01 contains dominant T cell reactive sites. Clin Exp Allergy (2004) 0.78
Experience with a new commercial skin testing kit to identify IgE-mediated penicillin allergy. Intern Med J (2008) 0.78
Immunogenetic characteristics of immunoglobulin E in allergic disease. Clin Exp Allergy (2008) 0.77
T-cell receptor peptides that inhibit the T-cell response to allergen induce transforming growth factor-beta 1 production. J Allergy Clin Immunol (1996) 0.77
Particulate masks and non-powdered gloves reduce latex allergen inhaled by healthcare workers. Clin Exp Allergy (2002) 0.77
T-cell receptor contact and MHC binding residues of a major rye grass pollen allergen T-cell epitope. J Allergy Clin Immunol (1999) 0.76
Specific monoclonal antibodies and human immunoglobulin E show that Hev b 5 is an abundant allergen in high protein powdered latex gloves. Clin Exp Allergy (2002) 0.76
Chlorhexidine anaphylaxis: a case report and review of the literature. Intern Med J (2001) 0.75
Functional analysis of cross-reactive immunoglobulin E antibodies: peanut-specific immunoglobulin E sensitizes basophils to tree nut allergens. Clin Exp Allergy (2005) 0.75
Emergency treatment of asthma: how are we doing? Intern Med J (2003) 0.75
Characterization of the human T cell response to rye grass pollen allergens Lol p 1 and Lol p 5. Allergy (2002) 0.75
Blocking antibodies in allergen immunotherapy: the Yin and Yang. Clin Exp Allergy (2004) 0.75
Immunotherapy in asthma. Thorax (1997) 0.75
Clonal analysis of CD4 mediated accessory function on the effector activity of human CD4+ T cell subsets. Clin Exp Allergy (1995) 0.75
What determines asthma phenotype? Respiratory infections and asthma. Am J Respir Crit Care Med (2000) 0.75
Latex allergy: towards immunotherapy for health care workers. Clin Exp Allergy (2002) 0.75
T lymphocytes in allergen-induced late-phase reactions and asthma. Int Arch Allergy Appl Immunol (1989) 0.75
Differential dependence of TH-0, TH-1 and TH-2 CD4+ T cells on co-stimulatory activity provided by the accessory molecule LFA-1. Clin Exp Allergy (1995) 0.75
Treating allergy: where to from here? Intern Med J (2009) 0.75
Murine B-cell and T-cell epitopes of the allergen Hev b 5 from natural rubber latex. Mol Immunol (1999) 0.75
Peanut allergy. Med J Aust (1997) 0.75
Inhibition of human T-cell responses to house dust mite allergens by a T-cell receptor peptide. J Allergy Clin Immunol (1994) 0.75